Ulfert Rand , Helmholtz Centre for Infection Research1, Braunschweig

The COVID-19 pandemic has pushed scientists around the globe into re-focusing their research. Lab scientists are on the front line making key discoveries in SARS-CoV-2 antiviral treatment, vaccination, and immunity to help solve this crisis, most of them entering uncharted experimental territory. Our lab has joined this world-wide effort and is supporting a number of collaborative projects in a variety of infection experiments under BSL3 conditions. Experimental challenges spanning from A, like antibodies, to Z, like zinc-finger antiviral protein, have been most diverse so far and required versatile and flexible approaches. Here, I will give an overview on these projects and our insights.